Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with unmet medical need. The company's pipeline includes three clinical-stage candidates: EDSIVO? (celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001 (a fully taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; and osanetant for the treatment of various neuroendocrine disorders.

AgroFresh Solutions delivers food preservation and waste reduction solutions for fresh produce. The company's products are: SmartFresh, which regulates the post-harvest ripening effects of ethylene; Harvista, which provides treatment of cherries and blueberries early in the growing season, and near-harvest management of apples and pears; FreshCloud Storage Insights?, which is an atmospheric monitoring system that provides guidance to producers and packers of fresh produce regarding storage conditions; LandSpring?, which is 1-Methylcyclopropene technology targeted to transplanted vegetable seedlings; and RipeLock, which is a packaging-based freshness technology solutions for fruits and vegetables.

Americold Realty Trust is a real estate investment trust. The company is an owner and operator of temperature-controlled warehouses. The company's segments include: warehouse, in which the company provides temperature-controlled warehouse storage and related handling and other warehouse services; third-party managed, in which the company manages warehouses on behalf of third parties and provides warehouse management services to several food retailers and manufacturers in customer-owned facilities, including some of its customers; and transportation, in which the company brokers and manages transportation of frozen and perishable food and other products for its customers.

Amyris is an industrial biotechnology company that applies its technology platform to engineer, manufacture and sell products into the Health and Wellness, Clean Beauty, and Flavor and Fragrance markets. The company's technology platform enables it to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into ingredients. The company is focused on the production of Biofene?, its brand of renewable farnesene, a long-chain, branched hydrocarbon molecule that it manufactures through fermentation using engineered microbes. The company's farnesene derivatives are sold in various products as nutrition, health, skincare, fragrances, solvents, and fragrance ingredients.

AVEO Pharmaceuticals is a biopharmaceutical company. The company's product candidates include: tivozanib, its key candidate, a vascular endothelial growth factor receptor tyrosine kinase inhibitor which has been investigated in several tumor types, including renal cell, hepatocellular, colorectal and breast cancers; Ficlatuzumab, a hepatocyte growth factor inhibitory antibody, which is being tested for the treatment of squamous cell carcinoma of the head and neck, acute myeloid leukemia, and pancreatic cancer; AV-203, an anti-ErbB3 specific monoclonal antibody with high ErbB3 affinity; and AV-380, a humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia.

Ellington Residential Mortgaging Real Estate Investment Trust is focused on acquiring, investing in, and managing residential mortgage- and real estate-related assets. The company conducts business through its subsidiaries, EARN OP GP LLC and Ellington Residential Mortgage LP. The company may acquire and mortgage servicing rights, credit risk transfer securities, residential mortgage loans, and other mortgage- and real estate-related assets. The company may also invest in other instruments, including forward-settling To-Be-Announced Agency pass-through certificates, interest rate swaps and swaptions, U.S. Treasury securities, Eurodollar and U.S. Treasury futures, other financial derivatives, and cash equivalents.

Financial Institutions is a financial holding company. Through its subsidiary, Five Star Bank, the company provides a range of banking services to consumer, commercial and municipal customers in Western and Central New York. Through its subsidiary, SDN Insurance Agency, LLC, the company sells various premium-based insurance policies on a commission basis to commercial and consumer customers. Through its subsidiaries, Courier Capital, LLC and HNP Capital, LLC, the company provides customized investment advice, wealth management, investment consulting and retirement plan services to individuals, businesses, institutions, foundations and retirement plans.

Lilis Energy is an independent oil and gas company focused on the exploration, acquisition, development, and production of oil and natural gas reserves from properties in the Permian Basin. The company's operations are focused on the Delaware Basin of the Permian in Winkler, Loving, and Reeves Counties, TX and Lea County, NM.

Reed's is the owner and maker of a portfolio of handcrafted beverages that is sold nationwide (including the natural and specialty food channel, convenience stores and on-premise locations, among others). The company's two primary brands are: Reed's Craft Ginger Beer, which is a ginger beer with different levels of fresh ginger content, ranging from its lightest-spiced Original, to its medium-spiced Extra, and to its spiciest Strongest; and Virgil's Handcrafted soda, which is a handcrafted soda that includes the handcrafted line, which includes root beer, vanilla cream, black cherry, and orange, and zero sugar line, which includes root beer, cola, black cherry, vanilla cream, orange and lemon-lime.

SIGA Technologies is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The company's primary product is an oral formulation of TPOXX?, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The United States Food and Drug Administration has approved oral TPOXX? for the treatment of smallpox.

Spark Energy is a holding company. Through its subsidiaries, the company is an independent retail energy services company. The company's segments include: Retail Electricity, where the company purchases electricity supply through physical and financial transactions with market counterparties and independent system operators and supplies electricity to residential and commercial consumers pursuant to fixed-price and variable-price contracts; and Retail Natural Gas, where the company purchases natural gas supply through physical and financial transactions with market counterparties and supplies natural gas to residential and commercial consumers pursuant to fixed-price and variable-price contracts.

Zynerba Pharmaceuticals is a clinical stage specialty pharmaceutical company focused on the development of pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, including Fragile X syndrome (FXS), Autism Spectrum Disorder (ASD), 22q11.2 Deletion Syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies (DEE). The company is evaluating Zygel?, a patent-protected transdermal cannabidiol gel for the treatment of FXS, DEE and ASD. Zygel is being developed as a clear gel that is designed to provide consistent, controlled drug delivery with once- or twice-daily dosing.